Literature DB >> 22057494

Photodynamic therapy of disseminated non-small cell lung carcinoma in a murine model.

Craig E Grossman1, Stephen Pickup, Amy Durham, E Paul Wileyto, Mary E Putt, Theresa M Busch.   

Abstract

BACKGROUND AND
OBJECTIVE: Photodynamic therapy (PDT) of thoracic malignancies involving the pleural surfaces is an active area of clinical investigation. The present report aims to characterize a model for PDT of disseminated non-small cell lung carcinoma (NSCLC) grown orthotopically in nude mice, and to evaluate the effect of PDT on tumor and normal tissues. STUDY
DESIGN: H460 human NSCLC cells were injected percutaneously into the thoracic cavity of nude mice. HPPH-PDT (1 mg/kg, 24 hours) was performed via the interstitial delivery (150 mW/cm) of 661 nm light to the thoracic cavity at fluences of 25-200 J/cm.
RESULTS: H460 tumors exhibited exponential growth within the thoracic cavity consisting of diffuse, gross nodular disease within 9 days after intrathoracic injection. Tumor volume, measured by magnetic resonance imaging (MRI), was highly correlated with the aggregate tumor mass extracted from the corresponding animal. Intrathoracic PDT at fluences of ≥50 J/cm produced significant decreases in tumor burden as compared to untreated controls, however, mortality increased with rising fluence. Accordingly, 50 J/cm was selected for MRI studies to measure intra-animal PDT effects. Tumor distribution favored the ventral (vs. dorsal), caudal (vs. cranial), and right (vs. left) sides of the thoracic cavity by MRI; PDT did not change this spatial pattern despite an overall effect on tumor burden. Histopathology revealed edema and fibrin deposition within the pulmonary interstitium and alveoli of the PDT-treated thoracic cavity, as well as occasional evidence of vascular disruption. Prominent neutrophil infiltration with a concomitant decline in the lymphocyte compartment was also noted in the lung parenchyma within 24 hours after PDT.
CONCLUSION: HPPH-PDT of an orthotopic model of disseminated NSCLC is both feasible and effective using intracavitary light delivery. We establish this animal model, together with the treatment and monitoring approaches, as novel and valuable methods for the pre-clinical investigation of intrathoracic PDT of disseminated pleural malignancies.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22057494      PMCID: PMC3676899          DOI: 10.1002/lsm.21102

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  64 in total

Review 1.  Palliative care in lung cancer.

Authors:  Betty Ferrell; Marianna Koczywas; Fred Grannis; Annie Harrington
Journal:  Surg Clin North Am       Date:  2011-04       Impact factor: 2.741

2.  Photodynamic therapy selectively enhances liposomal doxorubicin uptake in sarcoma tumors to rodent lungs.

Authors:  Cai Cheng; Elodie Debefve; Amina Haouala; Snezana Andrejevic-Blant; Thorsten Krueger; Jean-Pierre Ballini; Solange Peters; Laurent Decosterd; Hubert van den Bergh; Georges Wagnieres; Jean Y Perentes; Hans-Beat Ris
Journal:  Lasers Surg Med       Date:  2010-07       Impact factor: 4.025

3.  Intraoperative photodynamic therapy of the chest cavity in malignant pleural mesothelioma bearing rats.

Authors:  Thorsten Krueger; Youmin Pan; Nam Tran; Hans-Joerg Altermatt; Isabelle Opitz; Hans-Beat Ris
Journal:  Lasers Surg Med       Date:  2005-10       Impact factor: 4.025

4.  Interstitial laser photocoagulation and interstitial photodynamic therapy of normal lung parenchyma in the pig.

Authors:  D I Fielding; G Buonaccorsi; G Cowley; A M Johnston; G Hughes; M R Hetzel; S G Bown
Journal:  Lasers Med Sci       Date:  2001       Impact factor: 3.161

5.  Retrospective review of lung cancer patients with pleural dissemination after limited operations combined with parietal pleurectomy.

Authors:  Yasuhiko Ohta; Yosuke Shimizu; Isao Matsumoto; Masaya Tamura; Makoto Oda; Go Watanabe
Journal:  J Surg Oncol       Date:  2005-09-15       Impact factor: 3.454

6.  Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model.

Authors:  Bin Chen; Brian W Pogue; Xiaodong Zhou; Julia A O'Hara; Nicolas Solban; Eugene Demidenko; P Jack Hoopes; Tayyaba Hasan
Journal:  Clin Cancer Res       Date:  2005-01-15       Impact factor: 12.531

Review 7.  Photodynamic therapy as an adjunct to surgery for malignant pleural mesothelioma.

Authors:  Hans-Beat Ris
Journal:  Lung Cancer       Date:  2005-07       Impact factor: 5.705

8.  Operation and photodynamic therapy for pleural mesothelioma: 6-year follow-up.

Authors:  T L Moskal; T J Dougherty; J D Urschel; J G Antkowiak; A M Regal; D L Driscoll; H Takita
Journal:  Ann Thorac Surg       Date:  1998-10       Impact factor: 4.330

9.  Quantitative monitoring of adenocarcinoma development in rodents by magnetic resonance imaging.

Authors:  Joel R Garbow; Min Wang; Yian Wang; Ronald A Lubet; Ming You
Journal:  Clin Cancer Res       Date:  2008-03-01       Impact factor: 12.531

10.  Role of cytokines in photodynamic therapy-induced local and systemic inflammation.

Authors:  S O Gollnick; S S Evans; H Baumann; B Owczarczak; P Maier; L Vaughan; W C Wang; E Unger; B W Henderson
Journal:  Br J Cancer       Date:  2003-06-02       Impact factor: 7.640

View more
  8 in total

1.  Utility and applications of orthotopic models of human non-small cell lung cancer (NSCLC) for the evaluation of novel and emerging cancer therapeutics.

Authors:  Verline Justilien; Alan P Fields
Journal:  Curr Protoc Pharmacol       Date:  2013-10-08

2.  Fluorinated Photodynamic Therapy Device Tips and their Resistance to Fouling for In Vivo Sensitizer Release.

Authors:  Ashwini A Ghogare; Joann M Miller; Bikash Mondal; Alan M Lyons; Keith A Cengel; Theresa M Busch; Alexander Greer
Journal:  Photochem Photobiol       Date:  2015-11-04       Impact factor: 3.421

3.  Dextran-Benzoporphyrin Derivative (BPD) Coated Superparamagnetic Iron Oxide Nanoparticle (SPION) Micelles for T2-Weighted Magnetic Resonance Imaging and Photodynamic Therapy.

Authors:  Lesan Yan; Lijun Luo; Ahmad Amirshaghaghi; Joann Miller; Cathy Meng; Tianyan You; Theresa M Busch; Andrew Tsourkas; Zhiliang Cheng
Journal:  Bioconjug Chem       Date:  2019-11-08       Impact factor: 4.774

4.  Photodynamic therapy of human lung cancer xenografts in mice.

Authors:  Chukwumere Nwogu; Paula Pera; Wiam Bshara; Kristopher Attwood; Ravindra Pandey
Journal:  J Surg Res       Date:  2015-07-17       Impact factor: 2.192

5.  Fluence Rate Differences in Photodynamic Therapy Efficacy and Activation of Epidermal Growth Factor Receptor after Treatment of the Tumor-Involved Murine Thoracic Cavity.

Authors:  Craig E Grossman; Shirron L Carter; Julie Czupryna; Le Wang; Mary E Putt; Theresa M Busch
Journal:  Int J Mol Sci       Date:  2016-01-14       Impact factor: 5.923

6.  Early assessment of tumor response to photodynamic therapy using combined diffuse optical and diffuse correlation spectroscopy to predict treatment outcome.

Authors:  Patricia S P Thong; Kijoon Lee; Hui-Jin Toh; Jing Dong; Chuan-Sia Tee; Kar-Perng Low; Pui-Haan Chang; Ramaswamy Bhuvaneswari; Ngian-Chye Tan; Khee-Chee Soo
Journal:  Oncotarget       Date:  2017-03-21

7.  Chlorin e6-Coated Superparamagnetic Iron Oxide Nanoparticle (SPION) Nanoclusters as a Theranostic Agent for Dual-Mode Imaging and Photodynamic Therapy.

Authors:  Ahmad Amirshaghaghi; Lesan Yan; Joann Miller; Yonathan Daniel; Joel M Stein; Theresa M Busch; Zhiliang Cheng; Andrew Tsourkas
Journal:  Sci Rep       Date:  2019-02-22       Impact factor: 4.379

Review 8.  Animal models for photodynamic therapy (PDT).

Authors:  Zenildo Santos Silva; Sandra Kalil Bussadori; Kristianne Porta Santos Fernandes; Ying-Ying Huang; Michael R Hamblin
Journal:  Biosci Rep       Date:  2015-09-28       Impact factor: 3.840

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.